Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
518.00
Ask:
533.00
Spread: 15.00 (2.896%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Statement

27 Jan 2017 07:00

RNS Number : 2622V
Mortgage Advice Bureau(Holdings)PLC
27 January 2017
 

27 January 2017

Mortgage Advice Bureau (Holdings) plc ("MAB" or the "Group")

Pre-close Trading Update 

This announcement contains inside information.

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1), one of the UK's leading networks for mortgage intermediaries, today issues a pre-close trading update for the year ended 31 December 2016, ahead of publishing its final results announcement on Tuesday, 28 March 2017(1).

Revenue for the year ended 31 December 2016 was in line with market consensus and increased by 23% to £92m driven by a 23% increase in the average number of Advisers to 888 in the 12 months to 31 December 2016. The total number of Advisers had increased to 950 at 31 December 2016, an increase of 160 or 20% since last year end (790 at 31 December 2015). Although average revenue per adviser was flat in 2016 due to the impact of the lull in activity in the housing and mortgage market surrounding the EU referendum, MAB expects to see growth in the current year.

The Group's underlying profit before tax for the year ended 31 December 2016 was ahead of market consensus despite the impact of this lull. Following absorption of £0.4m of FSCS supplementary levies in the year ended 31 December 2016 which the FSCS recently announced for life and pensions advisers, general insurers and mortgage advisers, the Group's profit before tax was marginally ahead of market consensus.

At 31 December 2016, the Group had a balance sheet cash position of over £18m, including over £10m of unrestricted cash balances. 

Following confirmation that the Substantial Shareholding Exemption applies to the capital gain arising on MAB's sale of its 49% stake in Capital Private Finance Limited, no corporation tax is payable on the £2.7m capital gain. Accordingly, the £0.5m balance of the gain not already distributed will be distributed in full to shareholders by way of a special dividend of 1.1 pence per share (2).

The Council of Mortgage Lenders ("CML") recently published revised estimates for gross mortgage lending for 2016 and 2017 of £246bn and £248bn respectively, as well as publishing their first estimate for 2018 of £252bn; gross mortgage lending growth is therefore expected to be flat for each of 2017 and 2018. MAB remains focused on continuing its long track record of growing market share.

(1) It is expected that a proposed final dividend in respect of the year ended 31 December 2016 will be paid on 31 May 2017 to shareholders on the register at close of business on 5 May 2017.

(2) The special dividend will be paid on 3 March 2017 to shareholders on the register at close of business on 10 February 2017.

Peter Brodnicki, CEO of Mortgage Advice Bureau (Holdings) plc, said:

"Despite the uncertainty the EU referendum brought to the housing and mortgage markets last summer, MAB has delivered yet another strong performance. Activity levels picked up following the expected summer lull, and from this position the housing and mortgage markets are forecast to be flat over the next few years.

"Our increase in adviser numbers was ahead of our expectations last year and we remain confident about continued growth in 2017 and 2018, both organically and from new Appointed Representatives.

"Regardless of the EU referendum and predictions of flat housing and mortgage markets, MAB's future growth plans remain unchanged. Our strategy is very clear both in the short and longer term, and the investments made in 2016 form part of our longer term planning to maintain year on year market share growth and further strengthen MAB's overall market position."

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

David Preece, Chief Operating Officer

Lucy Tilley, Finance Director

Nominated Adviser and Joint Broker:

Zeus Capital +44 (0)20 3829 5000

Martin Green

Nicholas How

Pippa Underwood

 

Joint Broker:

Canaccord Genuity +44 (0)20 7523 8350

Andrew Buchanan

Kit Stephenson

Richard Andrews

 

Media Enquiries: 

investorrelations@mab.org.uk

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBCGDBCGDBGRL
Date   Source Headline
1st Dec 20255:25 pmRNSDirectors' Shareholdings and PDMR notification
18th Nov 20252:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20257:00 amRNSNotice of Capital Markets Day Update
7th Nov 20255:15 pmRNSHolding(s) in Company
4th Nov 20251:34 pmRNSDirector/PDMR Shareholding
16th Oct 202512:40 pmRNSDirector/PDMR Shareholding
16th Oct 202512:38 pmRNSGrant of Options, PDMR Dealing,Total Voting Rights
30th Sep 20254:43 pmRNSDirector/PDMR Shareholding
25th Sep 20254:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20255:01 pmRNSBlock listing Interim Review
23rd Sep 20257:00 amRNSInterim Results
17th Sep 20252:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNS-RNotice of HY25 Results and Investor Presentation
29th Aug 20251:13 pmRNSDirector/PDMR Shareholding
27th Aug 20254:26 pmRNSHolding(s) in Company
21st Aug 20253:01 pmRNSDirector/PDMR Shareholding
31st Jul 202511:32 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
22nd Jul 20255:59 pmRNSEBT Share Purchase
17th Jul 20259:46 amRNSDirector/PDMR Shareholding
16th Jul 20251:58 pmRNSHolding(s) in Company
9th Jul 20259:05 amRNS-RMAB Launches First-Time Buyer Campaign
3rd Jul 20259:54 amRNSDirector/PDMR Shareholding
27th Jun 20253:46 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSBoard Changes
18th Jun 202510:55 amRNSDirector/PDMR Shareholding
11th Jun 202510:18 amRNSHolding(s) in Company
3rd Jun 20252:47 pmRNSDirector/PDMR Shareholding
30th May 20253:52 pmRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSResults of Annual General Meeting
21st May 20257:00 amRNSAGM Trading Statement
16th May 202512:30 pmRNSDirector/PDMR Shareholding
6th May 202512:37 pmRNSHolding(s) in Company
1st May 20255:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 20255:15 pmRNSGrant of Options, PDMR Dealing and TVR
29th Apr 20258:48 amRNSNotice of AGM
17th Apr 20251:40 pmRNSHolding(s) in Company
16th Apr 20259:58 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20257:10 amRNSAnnual Report and Notice of AGM
1st Apr 20253:51 pmRNSDirector/PDMR Shareholding
27th Mar 20259:18 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirectorate Change
18th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
17th Mar 20253:40 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSBlock Admission Application
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation
18th Feb 20253:57 pmRNSDirector/PDMR Shareholding
17th Feb 20253:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.